Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| MRNA | Moderna, Inc. | 8.42% | 419.05 | 0.0% | $8674.93m | |
| BNTX | BioNTech SE | 17.80% | 414.44 | 0.0% | $1709.63m | |
| NVAX | Novavax, Inc. | 18.69% | 223.81 | 79.8% | $898.59m | |
| SNSS | Sunesis Pharmaceuticals, Inc. | -0.92% | 10.72 | 0.7% | $749.37m | |
| AMGN | Amgen, Inc. | -6.46% | 228.31 | 1.3% | $524.03m | |
| BIIB | Biogen, Inc. | 0.03% | 338.10 | 1.7% | $451.97m | |
| VRTX | Vertex Pharmaceuticals, Inc. | -0.23% | 199.59 | 1.9% | $424.11m | |
| GILD | Gilead Sciences, Inc. | -0.85% | 69.24 | 1.0% | $409.81m | |
| REGN | Regeneron Pharmaceuticals, Inc. | -0.95% | 580.95 | 2.7% | $330.19m | |
| ILMN | Illumina, Inc. | 1.24% | 504.60 | 3.5% | $271.58m | |
| NTLA | Intellia Therapeutics, Inc. | 5.87% | 146.94 | 2.3% | $204.93m | |
| SGEN | Seagen Inc. | 3.17% | 163.21 | 5.8% | $137.56m | |
| CRSP | CRISPR Therapeutics AG | 2.63% | 124.61 | 0.6% | $137.02m | |
| TBIO | Translate Bio, Inc. | 0.48% | 37.85 | 3.3% | $134.82m | |
| EXAS | EXACT Sciences Corp. | 1.56% | 105.83 | 18.1% | $131.45m |
Company Profile
10X Genomics, Inc. is a life science technology company, which engages in building products to interrogate, understand and master biology. Its integrated solutions include single cell transcriptomics, single cell genomics, single cell epigenomes, linked-reads genomics and spatial transcriptomics. The company’s products include Single Cell Gene Expression, Immune Profiling, CNV, ATAC, and Genome and Exome. 10X Genomics was founded by Serge Saxonov, Ben Hindson and Kevin D. Ness on July 2, 2012 and is headquartered in Pleasanton, CA.